TALEN

TALEN2-phf6

ID

ZDB-TALEN-131030-9

Name

TALEN2-phf6

Previous Names

None

Target

phf6 (1)

Target Sequence 1

5' - TCAGCCTTGGTCACATCT - 3'

Target Sequence 2

5' - TAGAAAAGCCTCCGATGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
cmg105	phf6

Expression

Gene expression in Wild Types + TALEN2-phf6

No data available

Phenotype

Phenotype resulting from TALEN2-phf6

No data available

Phenotype of all Fish created by or utilizing TALEN2-phf6

Phenotype	Fish	Conditions	Figures
whole organism phf6 expression decreased amount, abnormal	phf6^cmg105/+	standard conditions	Fig. S4 from Loontiens et al., 2020
T cell notch1a expression decreased amount, abnormal	phf6^cmg105/+; zdf8Tg	standard conditions	Fig. 7 from Loontiens et al., 2020
T cell phf6 expression decreased amount, abnormal	phf6^cmg105/+; zdf8Tg	standard conditions	Fig. 7 from Loontiens et al., 2020
thymus GFP expression increased amount, abnormal	phf6^cmg105/+; zdf8Tg	standard conditions	Fig. 7 from Loontiens et al., 2020
thymus increased size, abnormal	phf6^cmg105/+; zdf8Tg	standard conditions	Fig. 7 from Loontiens et al., 2020
whole organism precursor T-cell neoplasms present, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 1 from Loontiens et al., 2020
lymphocyte cisha expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte fat1a expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte nras expression increased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte tet1 expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte rb1 expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte myca expression increased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte usp7 expression increased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte gata3 expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte bcl11ba expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte notch1a expression increased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte ikzf1 expression decreased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020
lymphocyte mycb expression increased amount, abnormal	phf6^cmg105/+; cmg106Tg	standard conditions	Fig. 2 from Loontiens et al., 2020

Citations